European Progestin Club Guidelines for prevention and treatment of threatened or recurrent (habitual) miscarriage with progestogens

Adolf E. Schindler, Howard Carp, René Druckmann, Andrea R. Genazzani, Johannes Huber, Jorge Pasqualini, Karl W. Schweppe, J. Szekeres-Barthó

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

This guideline has been developed based on studied and clinical investigations. Therefore, it appears to be appropriate to use all the available evidence, which are very encouraging, in a summarized form to propose guidelines by a group of European experts in order to give the gynecologists, obstetricians and reproductive medicine specialists have direction with regard to the prevention or treatment of miscarriage for the benefit of the endangered pregnancies. There are a number of statements, opinions and guidelines already published for this topic, which are not entirely in agreement.

Original languageEnglish
Pages (from-to)447-449
Number of pages3
JournalGynecological Endocrinology
Volume31
Issue number6
DOIs
Publication statusPublished - Jun 1 2015

Fingerprint

Habitual Abortion
Progestins
Guidelines
Reproductive Medicine
Spontaneous Abortion
Pregnancy

Keywords

  • Miscarriage
  • Prevention
  • Progestogens

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Obstetrics and Gynaecology

Cite this

European Progestin Club Guidelines for prevention and treatment of threatened or recurrent (habitual) miscarriage with progestogens. / Schindler, Adolf E.; Carp, Howard; Druckmann, René; Genazzani, Andrea R.; Huber, Johannes; Pasqualini, Jorge; Schweppe, Karl W.; Szekeres-Barthó, J.

In: Gynecological Endocrinology, Vol. 31, No. 6, 01.06.2015, p. 447-449.

Research output: Contribution to journalArticle

Schindler, Adolf E. ; Carp, Howard ; Druckmann, René ; Genazzani, Andrea R. ; Huber, Johannes ; Pasqualini, Jorge ; Schweppe, Karl W. ; Szekeres-Barthó, J. / European Progestin Club Guidelines for prevention and treatment of threatened or recurrent (habitual) miscarriage with progestogens. In: Gynecological Endocrinology. 2015 ; Vol. 31, No. 6. pp. 447-449.
@article{8194fc66774d4bd684da74524a264d4f,
title = "European Progestin Club Guidelines for prevention and treatment of threatened or recurrent (habitual) miscarriage with progestogens",
abstract = "This guideline has been developed based on studied and clinical investigations. Therefore, it appears to be appropriate to use all the available evidence, which are very encouraging, in a summarized form to propose guidelines by a group of European experts in order to give the gynecologists, obstetricians and reproductive medicine specialists have direction with regard to the prevention or treatment of miscarriage for the benefit of the endangered pregnancies. There are a number of statements, opinions and guidelines already published for this topic, which are not entirely in agreement.",
keywords = "Miscarriage, Prevention, Progestogens",
author = "Schindler, {Adolf E.} and Howard Carp and Ren{\'e} Druckmann and Genazzani, {Andrea R.} and Johannes Huber and Jorge Pasqualini and Schweppe, {Karl W.} and J. Szekeres-Barth{\'o}",
year = "2015",
month = "6",
day = "1",
doi = "10.3109/09513590.2015.1017459",
language = "English",
volume = "31",
pages = "447--449",
journal = "Gynecological Endocrinology",
issn = "0951-3590",
publisher = "Informa Healthcare",
number = "6",

}

TY - JOUR

T1 - European Progestin Club Guidelines for prevention and treatment of threatened or recurrent (habitual) miscarriage with progestogens

AU - Schindler, Adolf E.

AU - Carp, Howard

AU - Druckmann, René

AU - Genazzani, Andrea R.

AU - Huber, Johannes

AU - Pasqualini, Jorge

AU - Schweppe, Karl W.

AU - Szekeres-Barthó, J.

PY - 2015/6/1

Y1 - 2015/6/1

N2 - This guideline has been developed based on studied and clinical investigations. Therefore, it appears to be appropriate to use all the available evidence, which are very encouraging, in a summarized form to propose guidelines by a group of European experts in order to give the gynecologists, obstetricians and reproductive medicine specialists have direction with regard to the prevention or treatment of miscarriage for the benefit of the endangered pregnancies. There are a number of statements, opinions and guidelines already published for this topic, which are not entirely in agreement.

AB - This guideline has been developed based on studied and clinical investigations. Therefore, it appears to be appropriate to use all the available evidence, which are very encouraging, in a summarized form to propose guidelines by a group of European experts in order to give the gynecologists, obstetricians and reproductive medicine specialists have direction with regard to the prevention or treatment of miscarriage for the benefit of the endangered pregnancies. There are a number of statements, opinions and guidelines already published for this topic, which are not entirely in agreement.

KW - Miscarriage

KW - Prevention

KW - Progestogens

UR - http://www.scopus.com/inward/record.url?scp=84938094239&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938094239&partnerID=8YFLogxK

U2 - 10.3109/09513590.2015.1017459

DO - 10.3109/09513590.2015.1017459

M3 - Article

VL - 31

SP - 447

EP - 449

JO - Gynecological Endocrinology

JF - Gynecological Endocrinology

SN - 0951-3590

IS - 6

ER -